ALPEN PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

TAX ID5223057471

KRS0000607043

Share capital2,535,500.00 zł

★ ★ ★ ★ ★ ★ ★ ★ ★ ★

No opinion. Add your first review

address

AL. ALEJE JEROZOLIMSKIE 100, 00-807 WARSZAWA

Show on map

Is this your company?Update company information to get new customers, get notified of new reviews, and more!

Register Data

Full name

ALPEN PHARMA POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

uses securityreCAPTCHA

Privacy – Terms of Use

Legal address

AL. ALEJE JEROZOLIMSKIE 100, 00-807 WARSZAWA

Show on map

NIP

5223057471

REGON

363769736

KRS

0000607043

Legal form

limited liability company

Register Address

AL. ALEJE JEROZOLIMSKIE 100, 00-807 WARSZAWA

Date of registration in KRS

2016-03-14

Date of commencement of economic activity

2016-03-14

Act signature

WA.XII NS-REJ.KRS/58065/24/548/ADE

Pkd codes

46.46.Z - Wholesale trade of pharmaceutical and medical products

10 - Manufacture of food products

11 - Beverage production

20 - Manufacture of chemicals and chemical products

47 - Retail trade

56 - Food service activities

58 - Publishing activities

70 - Head office activities and management consultancy

77 - Rental and leasing

86 - Healthcare

Payer VAT status

Active

Vat list bank account(s)

PL57 1020 1055 0000 9202 0463 8740

PL72 1020 1055 0000 9602 0363 9853

PL77 1020 1055 0000 9402 0363 9861

Company authorities

representation authorityMANAGEMENT

representation type

DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI JEST UPOWAŻNIONY KAŻDY Z CZŁONKÓW ZARZĄDU SAMODZIELNIE ORAZ PROKURENT SAMOISTNY SAMODZIELNIE

MANAGEMENT

Marcin Adam Kuryłek

Chairman Of The Board, 54 years old

shareholders

ALPEN PHARMA AG

100% 25355 udziałów o łącznej wartości 2.535.500,00 zł

Financial data

Net sales [PLN]

Gross profit / loss [PLN]

Automatically generated based on financial statements from KRS Registry

	2021	2022	2023
	M PLN	M PLN	M PLN	%
Gross profit (loss)	0,1	0,2	0,3	48,3
EBITDA	0,2	0,2	0,3	44,3
Short time liabilities	0,8	1,1	1,2	5,6
Equity capital	-1,3	-1,2	1	184,7
Operating profit (EBIT)	0,2	0,2	0,3	43,9
Assets	1,5	2	2,4	18,9
Net profit (loss)	0,1	0,1	0,2	78,1
Cash	0,3	0,4	0,5	36,3
Liabilities and provisions for liabilities	2,9	3,3	1,4	-57,2
Net income from sale	5,3	7,4	7,3	-1,2
Working assets	1,5	2	2,4	18,9
Depreciation	0	0	0	64,2
	%	%	%	p.p.
Profitability of capital	-10,1	-10,7	22,5	33,2
Equity capital to total assets	-88,5	-59,7	42,5	102,2
Gross profit margin	2,6	2,3	3,4	1,1
EBITDA Margin	3,7	3,1	4,5	1,4
	Days	Days	Days	Days
Short term commitment turnover cycle	59	56	59	3

Current financial liquidity indicator	1.7515697479248047	1.7552112340927124	2.0263397693634033	0,2
Net dept to EBITDA	8.677102088928223	7.178287982940674	-1.5580946207046509	-8,8